Federal Judge Rules Against Gilead in Lexiscan Generic Case By PacConAdmin | May 24, 2022 A federal judge in Delaware has ended an attempt by Gilead Sciences to defend its Lexiscan (regadenoson) cardiac stress agent from generic competition. Source: Drug Industry Daily Posted in Drug Industry Daily